title: Head and neck cancer in 2016: A watershed year for improvements in treatment?
authors.affiliation: Division of Hematology and Oncology, University of California, San Francisco, 1600 Divisadero Street, Room A739, San Francisco, California 94116, USA.
authors.forename: Alain P
authors.initials: AP
authors.lastname: Algazi
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Clinical and Translational Sciences Institute, University of California, San Francisco, 550 16th Street, Box 0558, San Francisco, California 94113, USA.
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Grandis
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging / Q000628:therapy*; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors; D011878:Radiotherapy
chemical_list: C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor